LYCOS RETRIEVER
Lamivudine
built 658 days ago
Clevudine was Superior to Lamivudine in the Patients with HBeAg Chronic. Exposure to PSI with no dose related adverse events or laboratory. TSX MGI, OTC MGIFF, a clinical stage developer of drugs for infectious diseases, has received preliminary four week interim results from a Phase II viral kinetics study in hepatitis C virus treatment naive patients which indicate that celgosivir an oral alpha glucosidase I inhibitor has no negative effects on the tolerability. PRNewswire content is expressly prohibited without.
Source: